QuiVad

Home / Sweden / Oncopeptides AB

Oncopeptides AB

Short position disclosed on September 22, 2026.

Follow

Evolution of the disclosed total

0%0.5%1%1.5%2%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 8.43% on August 19, 2021. The shaded band matches the twelve months of the first chart.

July 23, 2018 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
GSA Capital Partners LLP1.19%newSeptember 22, 2026

On the other side: the funds that hold Oncopeptides AB Titelia

Follow by RSS

Get the moves on Oncopeptides AB by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

439 disclosures on record for this share.
DateFund% of capitalEnd of publication
October 14, 2021Citadel Advisors LLC0.60%
October 13, 2021Worldquant LLC1.05%
October 13, 2021Citadel Advisors LLC0.57%
October 12, 2021Worldquant LLC0.92%
October 12, 2021Citadel Advisors LLC0.00%
October 11, 2021Qube Research & Technologies Limited0.89%
October 11, 2021Worldquant LLC0.80%
October 11, 2021Mangrove Partners0.73%
October 11, 2021Citadel Advisors LLC0.51%
October 8, 2021Mangrove Partners0.93%
October 8, 2021Worldquant LLC0.67%
October 8, 2021Citadel Advisors LLC0.00%
October 7, 2021Qube Research & Technologies Limited1.02%
October 7, 2021Citadel Advisors LLC0.70%
October 7, 2021Marshall Wace LLP0.00%
October 1, 2021Arrowstreet Capital Limited Partnership1.21%
September 30, 2021Citadel Advisors LLC0.00%
September 29, 2021PDT Partners LLC0.90%
September 28, 2021Marshall Wace LLP0.79%
September 20, 2021Qube Research & Technologies Limited0.67%
September 17, 2021Mangrove Partners1.10%
September 17, 2021Qube Research & Technologies Limited0.70%
September 17, 2021Citadel Advisors LLC0.59%
September 16, 2021Qube Research & Technologies Limited0.80%
September 16, 2021Citadel Advisors LLC0.67%
September 15, 2021Qube Research & Technologies Limited0.77%
September 14, 2021Citadel Advisors LLC0.74%
September 13, 2021Mangrove Partners1.00%
September 13, 2021Qube Research & Technologies Limited0.64%
September 10, 2021Citadel Advisors LLC0.82%
September 8, 2021Arrowstreet Capital Limited Partnership1.19%
September 8, 2021Mangrove Partners0.96%
September 7, 2021Citadel Advisors LLC0.76%
September 7, 2021Consonance Capital Management LP0.00%
September 2, 2021Marshall Wace LLP0.86%
September 2, 2021Citadel Advisors LLC0.81%
September 2, 2021Qube Research & Technologies Limited0.53%
August 31, 2021Qube Research & Technologies Limited0.00%
August 30, 2021Qube Research & Technologies Limited0.54%
August 27, 2021Qube Research & Technologies Limited0.00%
August 26, 2021Qube Research & Technologies Limited0.55%
August 24, 2021Citadel Advisors LLC1.06%
August 24, 2021Qube Research & Technologies Limited0.73%
August 23, 2021Citadel Advisors LLC1.12%
August 20, 2021Citadel Advisors LLC1.35%
August 20, 2021Capital Fund Management SA0.70%
August 20, 2021Qube Research & Technologies Limited0.61%
August 20, 2021Consonance Capital Management LP0.50%
August 20, 2021Worldquant LLC0.00%
August 19, 2021Citadel Advisors LLC1.22%

Download 439 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Sweden

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Oncopeptides AB, source Finansinspektionen, data as at September 22, 2026, https://www.quivad.com/action/oncopeptides-ab?page=6